Hello, everyone, and how are you today? A spot of rain has descended on the Pharmalot corporate campus, where we have successfully hustled the short people off to their schoolhouses. And not a moment too soon, either, since we have another busy day filled with reading documents, phoning people and, hopefully, learning some interesting tidbits. We know you can relate, so here a few items to get you started. We hope your day goes well and that you accomplish much. See you soon...
Cardinal Facility Banned From Shipping Controlled Substances (Associated Press)
US Launches Ambitious Plan To Research Alzheimer's Treatments (Reuters)
Who Isn't Looking At Amylin? (Bloomberg News)
Achillion Gets FDA Fast Track For Hepatitis C Drug (Reuters)
J&J Returns Impotence Pill Rights To Furiex (Reuters)
A Personalised Vaccine For Fighting Brain Tumors (London Evening Standard)
AstraZeneca Anti-Trust Fine Should Stand: EU Court Aide (Bloomberg News)
Merck KGgA Committed To Big Cost Cutting As Profits Fall (Pharma Times)
UK Lawmakers Urge Action On Drug Shortages (Reuters)
Hospira Recalls Pain Drug Cartridges On Overfill Concerns (Dow Jones)
AstraZeneca Cuts 400 Jobs In Sweden (The Local)
SNBL Claims To Have Fixed Troubled Facility (Outsourcing Pharma)
EDITOR'S NOTE: Please check this post for updates
rain pic thx to sterlic on flickr
2 Comments